CClinicalTrials.gg
CompletedNCT02180425AcneUpdated May 30, 2017

The Lipid Profile of the Skin Surface in Acne

An observational study in Acne, sponsored by University of California, Davis. Completed at 2 sites in United States. Open to participants aged 12 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-05-30.

Sponsored by University of California, Davis · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
30
Ages
12 Years to 30 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate the differences in the skin lipid profile of patients with and without acne. Secondly, the goal is to learn more about what the effects of retinoinds (topical and systemic) are on the the skin lipid profile. We hypothesize that the skin lipid profile of subjects with acne will be lower in inflammatory lipids in comparison to subjects without acne.

Read the detailed description

Skin lipid profile will be conducted via sebutapes- adhesive tapes that painlessly absorbs sebum from the face. These tapes will be placed on the face for 1 hour. A photograph of the face will be taken during each study visit. A sebumeter will also be used to measure skin sebum secretion rate.

02

Conditions studied

  • Acne

Browse trials for

Keywords

  • acne
  • lipid
  • tretinoin
  • isotretinoin
03

In context

Acne Vulgaris

730 studies on the registry are indexed under Acne Vulgaris; 86 are open to participants now.

This study's enrollment of 30 is below the median of 90 across 81 observational studies indexed under Acne Vulgaris.

Browse Acne Vulgaris studies →

Lead sponsor

University of California, Davis is the lead sponsor of 798 studies on the registry; 146 are open to participants now.

Of its 65 completed or terminated interventional studies of FDA-regulated products, 43 (66%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Subjects will be from the UC Davis Dermatology Clinic, surrounding dermatology clinics, from the UC Davis undergraduate campus, and from the California State University Sacramento campus.

Inclusion criteria

  • age 12 to 30 years
  • have been prescribed tretinoin OR isotretinoin

Exclusion criteria

Exclusion Criteria:

  • those who have taken isotretinoin (systemic)
  • those who used tretinoin or other topical retinoid within two weeks of starting the study
  • those with seborrheic dermatitis, rosacea, or polycystic ovary syndrome
  • those who are pregnant, prisoners, or cognitively impaired
  • those who do not fit the inclusion criteria
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
30 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • Healthy Group

    The subjects in this group do not have a history of acne.

  • Acne Group, Topical Retinoid

    These subjects have been prescribed a topical retinoid for their acne. They will participate in the study for a period of 1 month.

    Drug: Tretinoin or Adapalene

  • Acne Group, Isotretinoin

    These subjects have been prescribed isotretinoin for their acne. They will participate in the study for a period of 5-6 months.

    Drug: Isotretinoin

Interventions

  • DrugTretinoin or Adapalene

    Subjects will apply a pea sized amount of topical retinoid cream once daily at night for 30 days. Subjects will return for a follow-up visit.

    Also known as: Retin A

  • DrugIsotretinoin

    Subjects will take one pill once daily for 5 months. Subjects will return after 1 month and after 4-5 months of treatment for skin lipid profiling.

    Also known as: Accutane

06

What researchers measure

Primary outcomes

  1. Skin lipid profile of acne and healthy patients

    Compare the skin lipid profile of acne and healthy patients at baseline

    Time frame: baseline visit

Secondary outcomes

  1. Skin lipid profile of acne patients after treatment

    Patients in the topical retinoid group will have their lipids evaluated after 1 month of treatment. Patients in the systemic retinoid (isotretinoin) group will have their lipids evaluated after 1 and 4-5 months of treatment.

    Time frame: at 1 month and 4-5 months of treatment

07

Study locations

2 sites
  • Dermatology Research Area
    Davis, California 95616, United States
  • UC Davis Department of Dermatology
    Sacramento, California 95816, United States
08

References and documents

Publications

  • Thody AJ, Shuster S. Control and function of sebaceous glands. Physiol Rev. 1989 Apr;69(2):383-416. doi: 10.1152/physrev.1989.69.2.383. PubMed 2648418 ↗
  • Blume U, Verschoore M, Poncet M, Czernielewski J, Orfanos CE, Schaefer H. The vellus hair follicle in acne: hair growth and sebum excretion. Br J Dermatol. 1993 Jul;129(1):23-7. doi: 10.1111/j.1365-2133.1993.tb03306.x. PubMed 8369207 ↗
  • Zouboulis CC, Baron JM, Bohm M, Kippenberger S, Kurzen H, Reichrath J, Thielitz A. Frontiers in sebaceous gland biology and pathology. Exp Dermatol. 2008 Jun;17(6):542-51. doi: 10.1111/j.1600-0625.2008.00725.x. PubMed 18474083 ↗
  • Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol. 1997 Jun;36(6):416-8. doi: 10.1046/j.1365-4362.1997.00099.x. No abstract available. PubMed 9248884 ↗
  • Morello AM, Downing DT, Strauss JS. Octadecadienoic acids in the skin surface lipids of acne patients and normal subjects. J Invest Dermatol. 1976 May;66(5):319-23. doi: 10.1111/1523-1747.ep12482300. PubMed 131844 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 30, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02180425
Lead sponsor
University of California, Davis
Responsible party
Sponsor
First posted
Jul 2, 2014
Start date
Nov 2013
Primary completion
May 2015
Completion
Jul 2015
Last update
May 30, 2017

Study contacts

Raja K Sivamani, MD
principal investigator · UC Davis

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion